 | • レポートコード：MRC23Q35869 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（2-3日） • 産業分類：医療 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のコリンエステラーゼ活性試験市場について調査・分析し、世界のコリンエステラーゼ活性試験市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（血漿、赤血球、血漿＆赤血球（全血））、用途別セグメント分析（病院、診療所、学術研究機関、法医学研究所、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Merck KGaA、BioVision Inc、Thermo Fisher Scientific、Creative BioMart、Arbor Assays、BioAssay Systems、Abnova、Immunochemistry Technologies, LLC、Novus Biologicals、The Tintometer Ltd、Securetec、AnaSpec, Inc.、Universal Biologicals、Kaneka Eurogentec S.A.などが含まれています。 世界のコリンエステラーゼ活性試験市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、コリンエステラーゼ活性試験市場規模を推定する際に考慮しました。本レポートは、コリンエステラーゼ活性試験の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、コリンエステラーゼ活性試験に関するビジネス上の意思決定に役立てることを目的としています。 ・コリンエステラーゼ活性試験市場の概要 - コリンエステラーゼ活性試験のタイプ別セグメント - 世界のコリンエステラーゼ活性試験市場規模：タイプ別分析（血漿、赤血球、血漿＆赤血球（全血）） - コリンエステラーゼ活性試験の用途別セグメント - 世界のコリンエステラーゼ活性試験市場規模：用途別分析（病院、診療所、学術研究機関、法医学研究所、その他） - 世界のコリンエステラーゼ活性試験市場規模予測（2018年-2029年） ・コリンエステラーゼ活性試験市場の成長トレンド - コリンエステラーゼ活性試験の地域別市場規模（2018年-2029年） - コリンエステラーゼ活性試験市場ダイナミクス - コリンエステラーゼ活性試験の業界動向 - コリンエステラーゼ活性試験市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：血漿、赤血球、血漿＆赤血球（全血） - 世界のコリンエステラーゼ活性試験のタイプ別市場規模（2018年-2023年） - 世界のコリンエステラーゼ活性試験のタイプ別市場規模（2024年-2029年） ・用途別セグメント：病院、診療所、学術研究機関、法医学研究所、その他 - 世界のコリンエステラーゼ活性試験の用途別市場規模（2018年-2023年） - 世界のコリンエステラーゼ活性試験の用途別市場規模（2024年-2029年） ・コリンエステラーゼ活性試験の地域別市場規模 - 北米のコリンエステラーゼ活性試験市場規模（2018年-2029年） - アメリカのコリンエステラーゼ活性試験市場規模（2018年-2029年） - ヨーロッパのコリンエステラーゼ活性試験市場規模（2018年-2029年） - アジア太平洋のコリンエステラーゼ活性試験市場規模（2018年-2029年） - 中国のコリンエステラーゼ活性試験市場規模（2018年-2029年） - 日本のコリンエステラーゼ活性試験市場規模（2018年-2029年） - 韓国のコリンエステラーゼ活性試験市場規模（2018年-2029年） - インドのコリンエステラーゼ活性試験市場規模（2018年-2029年） - オーストラリアのコリンエステラーゼ活性試験市場規模（2018年-2029年） - 中南米のコリンエステラーゼ活性試験市場規模（2018年-2029年） - 中東・アフリカのコリンエステラーゼ活性試験市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Merck KGaA、BioVision Inc、Thermo Fisher Scientific、Creative BioMart、Arbor Assays、BioAssay Systems、Abnova、Immunochemistry Technologies, LLC、Novus Biologicals、The Tintometer Ltd、Securetec、AnaSpec, Inc.、Universal Biologicals、Kaneka Eurogentec S.A. ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Cholinesterase Activity Testing market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Cholinesterase Activity Testing is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Cholinesterase Activity Testing is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Cholinesterase Activity Testing in Hospitals is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Cholinesterase Activity Testing include Merck KGaA, BioVision Inc, Thermo Fisher Scientific, Creative BioMart, Arbor Assays, BioAssay Systems, Abnova, Immunochemistry Technologies, LLC and Novus Biologicals, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cholinesterase Activity Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cholinesterase Activity Testing.
The Cholinesterase Activity Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Cholinesterase Activity Testing market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cholinesterase Activity Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Merck KGaA
BioVision Inc
Thermo Fisher Scientific
Creative BioMart
Arbor Assays
BioAssay Systems
Abnova
Immunochemistry Technologies, LLC
Novus Biologicals
The Tintometer Ltd
Securetec
AnaSpec, Inc.
Universal Biologicals
Kaneka Eurogentec S.A.
Segment by Type
Plasma
RBC
Both Plasma & RBC (Whole Blood)
Segment by Application
Hospitals
Diagnostic Centers
Academic and Research Institutes
Forensic Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cholinesterase Activity Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cholinesterase Activity Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Plasma
1.2.3 RBC
1.2.4 Both Plasma & RBC (Whole Blood)
1.3 Market by Application
1.3.1 Global Cholinesterase Activity Testing Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Diagnostic Centers
1.3.4 Academic and Research Institutes
1.3.5 Forensic Laboratories
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cholinesterase Activity Testing Market Perspective (2018-2029)
2.2 Cholinesterase Activity Testing Growth Trends by Region
2.2.1 Global Cholinesterase Activity Testing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Cholinesterase Activity Testing Historic Market Size by Region (2018-2023)
2.2.3 Cholinesterase Activity Testing Forecasted Market Size by Region (2024-2029)
2.3 Cholinesterase Activity Testing Market Dynamics
2.3.1 Cholinesterase Activity Testing Industry Trends
2.3.2 Cholinesterase Activity Testing Market Drivers
2.3.3 Cholinesterase Activity Testing Market Challenges
2.3.4 Cholinesterase Activity Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cholinesterase Activity Testing Players by Revenue
3.1.1 Global Top Cholinesterase Activity Testing Players by Revenue (2018-2023)
3.1.2 Global Cholinesterase Activity Testing Revenue Market Share by Players (2018-2023)
3.2 Global Cholinesterase Activity Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cholinesterase Activity Testing Revenue
3.4 Global Cholinesterase Activity Testing Market Concentration Ratio
3.4.1 Global Cholinesterase Activity Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cholinesterase Activity Testing Revenue in 2022
3.5 Cholinesterase Activity Testing Key Players Head office and Area Served
3.6 Key Players Cholinesterase Activity Testing Product Solution and Service
3.7 Date of Enter into Cholinesterase Activity Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cholinesterase Activity Testing Breakdown Data by Type
4.1 Global Cholinesterase Activity Testing Historic Market Size by Type (2018-2023)
4.2 Global Cholinesterase Activity Testing Forecasted Market Size by Type (2024-2029)
5 Cholinesterase Activity Testing Breakdown Data by Application
5.1 Global Cholinesterase Activity Testing Historic Market Size by Application (2018-2023)
5.2 Global Cholinesterase Activity Testing Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Cholinesterase Activity Testing Market Size (2018-2029)
6.2 North America Cholinesterase Activity Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Cholinesterase Activity Testing Market Size by Country (2018-2023)
6.4 North America Cholinesterase Activity Testing Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cholinesterase Activity Testing Market Size (2018-2029)
7.2 Europe Cholinesterase Activity Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Cholinesterase Activity Testing Market Size by Country (2018-2023)
7.4 Europe Cholinesterase Activity Testing Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cholinesterase Activity Testing Market Size (2018-2029)
8.2 Asia-Pacific Cholinesterase Activity Testing Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Cholinesterase Activity Testing Market Size by Region (2018-2023)
8.4 Asia-Pacific Cholinesterase Activity Testing Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cholinesterase Activity Testing Market Size (2018-2029)
9.2 Latin America Cholinesterase Activity Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Cholinesterase Activity Testing Market Size by Country (2018-2023)
9.4 Latin America Cholinesterase Activity Testing Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cholinesterase Activity Testing Market Size (2018-2029)
10.2 Middle East & Africa Cholinesterase Activity Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Cholinesterase Activity Testing Market Size by Country (2018-2023)
10.4 Middle East & Africa Cholinesterase Activity Testing Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck KGaA
11.1.1 Merck KGaA Company Detail
11.1.2 Merck KGaA Business Overview
11.1.3 Merck KGaA Cholinesterase Activity Testing Introduction
11.1.4 Merck KGaA Revenue in Cholinesterase Activity Testing Business (2018-2023)
11.1.5 Merck KGaA Recent Development
11.2 BioVision Inc
11.2.1 BioVision Inc Company Detail
11.2.2 BioVision Inc Business Overview
11.2.3 BioVision Inc Cholinesterase Activity Testing Introduction
11.2.4 BioVision Inc Revenue in Cholinesterase Activity Testing Business (2018-2023)
11.2.5 BioVision Inc Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Detail
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Cholinesterase Activity Testing Introduction
11.3.4 Thermo Fisher Scientific Revenue in Cholinesterase Activity Testing Business (2018-2023)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Creative BioMart
11.4.1 Creative BioMart Company Detail
11.4.2 Creative BioMart Business Overview
11.4.3 Creative BioMart Cholinesterase Activity Testing Introduction
11.4.4 Creative BioMart Revenue in Cholinesterase Activity Testing Business (2018-2023)
11.4.5 Creative BioMart Recent Development
11.5 Arbor Assays
11.5.1 Arbor Assays Company Detail
11.5.2 Arbor Assays Business Overview
11.5.3 Arbor Assays Cholinesterase Activity Testing Introduction
11.5.4 Arbor Assays Revenue in Cholinesterase Activity Testing Business (2018-2023)
11.5.5 Arbor Assays Recent Development
11.6 BioAssay Systems
11.6.1 BioAssay Systems Company Detail
11.6.2 BioAssay Systems Business Overview
11.6.3 BioAssay Systems Cholinesterase Activity Testing Introduction
11.6.4 BioAssay Systems Revenue in Cholinesterase Activity Testing Business (2018-2023)
11.6.5 BioAssay Systems Recent Development
11.7 Abnova
11.7.1 Abnova Company Detail
11.7.2 Abnova Business Overview
11.7.3 Abnova Cholinesterase Activity Testing Introduction
11.7.4 Abnova Revenue in Cholinesterase Activity Testing Business (2018-2023)
11.7.5 Abnova Recent Development
11.8 Immunochemistry Technologies, LLC
11.8.1 Immunochemistry Technologies, LLC Company Detail
11.8.2 Immunochemistry Technologies, LLC Business Overview
11.8.3 Immunochemistry Technologies, LLC Cholinesterase Activity Testing Introduction
11.8.4 Immunochemistry Technologies, LLC Revenue in Cholinesterase Activity Testing Business (2018-2023)
11.8.5 Immunochemistry Technologies, LLC Recent Development
11.9 Novus Biologicals
11.9.1 Novus Biologicals Company Detail
11.9.2 Novus Biologicals Business Overview
11.9.3 Novus Biologicals Cholinesterase Activity Testing Introduction
11.9.4 Novus Biologicals Revenue in Cholinesterase Activity Testing Business (2018-2023)
11.9.5 Novus Biologicals Recent Development
11.10 The Tintometer Ltd
11.10.1 The Tintometer Ltd Company Detail
11.10.2 The Tintometer Ltd Business Overview
11.10.3 The Tintometer Ltd Cholinesterase Activity Testing Introduction
11.10.4 The Tintometer Ltd Revenue in Cholinesterase Activity Testing Business (2018-2023)
11.10.5 The Tintometer Ltd Recent Development
11.11 Securetec
11.11.1 Securetec Company Detail
11.11.2 Securetec Business Overview
11.11.3 Securetec Cholinesterase Activity Testing Introduction
11.11.4 Securetec Revenue in Cholinesterase Activity Testing Business (2018-2023)
11.11.5 Securetec Recent Development
11.12 AnaSpec, Inc.
11.12.1 AnaSpec, Inc. Company Detail
11.12.2 AnaSpec, Inc. Business Overview
11.12.3 AnaSpec, Inc. Cholinesterase Activity Testing Introduction
11.12.4 AnaSpec, Inc. Revenue in Cholinesterase Activity Testing Business (2018-2023)
11.12.5 AnaSpec, Inc. Recent Development
11.13 Universal Biologicals
11.13.1 Universal Biologicals Company Detail
11.13.2 Universal Biologicals Business Overview
11.13.3 Universal Biologicals Cholinesterase Activity Testing Introduction
11.13.4 Universal Biologicals Revenue in Cholinesterase Activity Testing Business (2018-2023)
11.13.5 Universal Biologicals Recent Development
11.14 Kaneka Eurogentec S.A.
11.14.1 Kaneka Eurogentec S.A. Company Detail
11.14.2 Kaneka Eurogentec S.A. Business Overview
11.14.3 Kaneka Eurogentec S.A. Cholinesterase Activity Testing Introduction
11.14.4 Kaneka Eurogentec S.A. Revenue in Cholinesterase Activity Testing Business (2018-2023)
11.14.5 Kaneka Eurogentec S.A. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details